Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study

• Главные авторы: Keigo Koda (Автор), Yasunori Enomoto (Автор), Yoichiro Aoshima (Автор), Yusuke Amano (Автор), Shinpei Kato (Автор), Hirotsugu Hasegawa (Автор), Takashi Matsui (Автор), Koshi Yokomura (Автор), Eisuke Mochizuki (Автор), Shun Matsuura (Автор), Naoki Koshimizu (Автор), Meiko Morita (Автор), Suguru Kojima (Автор), Ayano Watanabe (Автор), Yoshiyuki Oyama (Автор), Masaki Ikeda (Автор), Hideki Kusagaya (Автор), Tomohiro Uto (Автор), Jun Sato (Автор), Shiro Imokawa (Автор), Masato Kono (Автор), Dai Hashimoto (Автор), Yosuke Kamiya (Автор), Mikio Toyoshima (Автор), Kazuhiro Asada (Автор), Masako Morita (Автор), Masashi Mikamo (Автор), Hideki Yasui (Автор), Hironao Hozumi (Автор), Masato Karayama (Автор), Yuzo Suzuki (Автор), Kazuki Furuhashi (Автор), Tomoyuki Fujisawa (Автор), Noriyuki Enomoto (Автор), Yutaro Nakamura (Автор), Naoki Inui (Автор), Takafumi Suda (Автор)
• Формат: ‌
• Опубликовано: SAGE Publishing, 2022-06-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Introduction: Although recent advances in chemotherapy for lung cancer are remarkable, most clinical trials have excluded patients with interstitial lung disease (ILD) due to the concern of developing acute exacerbation (AE) of ILD. Hence, accumulating original evidence of cancer treatment for this...